- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 5/097 - Tripeptides le premier amino-acide étant hétérocyclique, p. ex. Pro, His, Trp, p. ex. thyrolibérine, mélanostatine
Détention brevets de la classe C07K 5/097
Brevets de cette classe: 260
Historique des publications depuis 10 ans
|
27
|
30
|
18
|
21
|
17
|
22
|
20
|
19
|
16
|
16
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Onyx Therapeutics, Inc. | 65 |
9 |
| Sederma | 263 |
7 |
| Trustees of Tufts College | 1003 |
6 |
| Hoffmann-La Roche Inc. | 3876 |
5 |
| Northwestern University | 3593 |
5 |
| Wisconsin Alumni Research Foundation | 3905 |
4 |
| Enanta Pharmaceuticals, Inc. | 427 |
4 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 884 |
4 |
| Shanghai Lumosa Therapeutics Co., Ltd. | 14 |
4 |
| University of Cincinnati | 935 |
4 |
| viDA Therapeutics Inc. | 15 |
4 |
| Onkure, Inc. | 29 |
4 |
| The Regents of the University of California | 20987 |
3 |
| The Johns Hopkins University | 5958 |
3 |
| Purdue Research Foundation | 3993 |
3 |
| Cornell University | 3459 |
3 |
| Escape Therapeutics, Inc. | 28 |
3 |
| The Governors of the University of Alberta | 881 |
3 |
| Molecular Transfer, Inc. | 25 |
3 |
| Research & Business Foundation Sungkyunkwan University | 2209 |
3 |
| Autres propriétaires | 176 |